EMA ISG Meeting 26 June 2023 – EMA Highlights Published EMA ISG Meeting 26 June 2023 – EMA Highlights Published The European Medicines Agency (EMA) has published the highlights from... EMA ISG Meeting 26 June 2023 – EMA Highlights Published
MHRA Marketing Authorisations Granted 15 August to 31 August 2023 MHRA Marketing Authorisations Granted 15 August to 31 August 2023 MHRA granted two OTC licences during 15 – 31 August... MHRA Marketing Authorisations Granted 15 August to 31 August 2023
DHSC Consultation – Disclosure of Industry Payments to the Healthcare Sector DHSC Consultation – Disclosure of Industry Payments to the Healthcare Sector The Department of Health and Social Care (DHSC) has... DHSC Consultation – Disclosure of Industry Payments to the Healthcare Sector
MHRA Email Update – Reporting Requirements for Medicine Shortages and Discontinuations MHRA Email Update – Reporting Requirements for Medicine Shortages and Discontinuations MHRA has updated the guidance on reporting requirements for... MHRA Email Update – Reporting Requirements for Medicine Shortages and Discontinuations
MHRA Public Consultation on the Removal of the European Commission Decision Reliance Procedure Route to Market MHRA Public Consultation on the Removal of the European Commission Decision Reliance Procedure Route to Market The Medicines and Healthcare... MHRA Public Consultation on the Removal of the European Commission Decision Reliance Procedure Route to Market
MHRA Pharmacovigilance Inspection Metrics MHRA Pharmacovigilance Inspection Metrics MHRA has published their Pharmacovigilance Inspection Metrics Report with information from April 2021 – March 2022. MHRA Pharmacovigilance Inspection Metrics
MHRA Publishes Updated List of Medicines That Cannot Be Exported from UK MHRA has updated its list of medicines that cannot be exported from UK MHRA has updated its list of medicines... MHRA Publishes Updated List of Medicines That Cannot Be Exported from UK
MHRA International Recognition Procedure – PAGB Summary MHRA International Recognition Procedure – PAGB Summary MHRA has published guidance on a new international recognition route for medicines utilising... MHRA International Recognition Procedure – PAGB Summary
MHRA Guidance – Nitrosamines Impurities in Medicines MHRA Guidance – Nitrosamines Impurities in Medicines MHRA has published guidance to help medicine manufacturers meet safe limits on levels... MHRA Guidance – Nitrosamines Impurities in Medicines
PAGB Reclassification Workshop PAGB Reclassification Workshop Reclassification is a vital part of PAGB’s work and we are pleased to be running our very... PAGB Reclassification Workshop
EMA – IRIS Platform Transition and Webinar EMA – IRIS Platform Transition and Webinar EMA is working on the transition of regulatory procedures for Product Lifecycle Management... EMA – IRIS Platform Transition and Webinar
MHRA Publishes Marketing Authorisations Granted 1 August to 14 August 2023 MHRA Marketing Authorisations Granted 1 August to 14 August 2023 MHRA granted three OTC licences during 1 – 14 August... MHRA Publishes Marketing Authorisations Granted 1 August to 14 August 2023